Login / Signup

Adjuvant system AS01: from mode of action to effective vaccines.

Francois RomanWivine BurnyMaria Angeles CeregidoBéatrice LaupèzeStéphane T TemmermanLucile WarterMargherita Coccia
Published in: Expert review of vaccines (2024)
Initial expectations that adjuvantation with AS01 could support effective vaccine responses and contribute to disease control have been realized. Investigation of the utility of AS01 in vaccines to prevent other challenging diseases, such as tuberculosis, is ongoing, together with efforts to fully define its mechanisms of action in different vaccine settings.
Keyphrases
  • early stage
  • mycobacterium tuberculosis
  • quality improvement
  • hiv aids
  • emergency department
  • pulmonary tuberculosis
  • hepatitis c virus
  • hiv infected